Danielle B Rice1,2, Brett D Thombs3,4,5,6,7,8,9. 1. Lady Davis Institute of the Jewish General Hospital, 4333 Côte-Sainte-Catherine Road,, Montréal, Québec, H3T 1E4, Canada. 2. Department of Psychology, McGill University, Montreal, Canada. 3. Lady Davis Institute of the Jewish General Hospital, 4333 Côte-Sainte-Catherine Road,, Montréal, Québec, H3T 1E4, Canada. brett.thombs@mcgill.ca. 4. Department of Psychology, McGill University, Montreal, Canada. brett.thombs@mcgill.ca. 5. Department of Psychiatry, McGill University, Montreal, Canada. brett.thombs@mcgill.ca. 6. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. brett.thombs@mcgill.ca. 7. Department of Medicine, McGill University, Montreal, Canada. brett.thombs@mcgill.ca. 8. Department of Educational and Counselling Psychology, McGill University, Montreal, Canada. brett.thombs@mcgill.ca. 9. Department of Biomedical Ethics Unit, McGill University, Montreal, Canada. brett.thombs@mcgill.ca.
Abstract
PURPOSE OF REVIEW: This review presents evidence on support group effectiveness in common diseases, research on support groups in systemic sclerosis (SSc), and work underway by the Scleroderma Patient-centered Intervention Network in collaboration with patient organizations to train SSc support group leaders in order to improve support group access and the experiences of support groups for members and leaders. RECENT FINDINGS: Giving and receiving emotional and practical support from others with SSc is an important reason that individuals with SSc attend support groups, but many patients cannot access support groups. SSc support group leaders report confidence in their ability to facilitate groups, but are less confident in tasks such as managing group dynamics and sustaining the group. The Scleroderma Support group Leader EDucation (SPIN-SSLED) Program was developed to provide training to support group leaders and was recently tested through a feasibility trial. A full-scale trial will commence in 2019.
PURPOSE OF REVIEW: This review presents evidence on support group effectiveness in common diseases, research on support groups in systemic sclerosis (SSc), and work underway by the Scleroderma Patient-centered Intervention Network in collaboration with patient organizations to train SSc support group leaders in order to improve support group access and the experiences of support groups for members and leaders. RECENT FINDINGS: Giving and receiving emotional and practical support from others with SSc is an important reason that individuals with SSc attend support groups, but many patients cannot access support groups. SSc support group leaders report confidence in their ability to facilitate groups, but are less confident in tasks such as managing group dynamics and sustaining the group. The Scleroderma Support group Leader EDucation (SPIN-SSLED) Program was developed to provide training to support group leaders and was recently tested through a feasibility trial. A full-scale trial will commence in 2019.
Entities:
Keywords:
Rare disease; Scleroderma; Social support; Support groups; Systemic sclerosis
Authors: Linda Kwakkenbos; Lisa R Jewett; Murray Baron; Susan J Bartlett; Dan Furst; Karen Gottesman; Dinesh Khanna; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Serge Poiraudeau; Maureen Sauve; Warren R Nielson; Janet L Poole; Shervin Assassi; Isabelle Boutron; Carolyn Ells; Cornelia Hm van den Ende; Marie Hudson; Ann Impens; Annett Körner; Catarina Leite; Angela Costa Maia; Cindy Mendelson; Janet Pope; Russell J Steele; Maria E Suarez-Almazor; Sara Ahmed; Stephanie Coronado-Montoya; Vanessa C Delisle; Shadi Gholizadeh; Yeona Jang; Brooke Levis; Katherine Milette; Sarah D Mills; Ilya Razykov; Rina S Fox; Brett D Thombs Journal: BMJ Open Date: 2013-08-07 Impact factor: 2.692
Authors: Stephanie T Gumuchian; Sandra Peláez; Vanessa C Delisle; Marie-Eve Carrier; Lisa R Jewett; Ghassan El-Baalbaki; Catherine Fortune; Marie Hudson; Ann Impens; Annett Körner; Jennifer Persmann; Linda Kwakkenbos; Susan J Bartlett; Brett D Thombs Journal: PLoS One Date: 2016-03-23 Impact factor: 3.240